Application
18315472 · SUBSTITUTED PYRROLO[3,2-c]PYRIDINES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER
Filed 2023-05-10 · Granted The official file ↗ · Art unit 1624 · Examiner Douglas M Willis Typical · CPC C07D 471/04 · Dana-Farber Cancer Institute, Inc. · GREENBERG TRAURIG, LLP (BOS)
Office actions
2
first was Restriction requirement
RCEs
0
no appeal
To first action
27.8 mo
to disposition 40.1 mo
Statutes raised
102 103 112
2 actions read